Screener
iRadimed IRMD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from iRadimed’s reported figures.
Based on trailing twelve months.
The source filing: iRadimed’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
FAQ
- What is iRadimed's EBITDA margin?
- iRadimed (IRMD) reported EBITDA margin of 34.1% in Q1 2026.
- How has iRadimed's EBITDA margin changed year-over-year?
- iRadimed's EBITDA margin increased by 9.2% year-over-year, from 31.2% to 34.1%.
- What is the long-term trend for iRadimed's EBITDA margin?
- Over 3 years (2021 to 2025), iRadimed's EBITDA margin has grown at a 6.7% compound annual growth rate (CAGR), from 26.8% to 32.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about iRadimed's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude